Y-mAbs Therapeutics, Inc. Financial Ratios — YMAB Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-35.03	-35.46	-44	-68.5	-32.06	-53.96	-15.91	-23.95
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	89.38	92.8	88.41	86.54	82.61
EBITDA Margin (%)	- -	- -	- -	- -	-576.09	-328.54	-143.98	-29.4	-34.97
Operating Margin (%)	- -	- -	- -	- -	-578	-330.78	-145.27	-30.27	-35.58
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	-575.12	-158.39	-146.43	-24.6	-34
Profit Margin (%)	- -	- -	- -	- -	-575.12	-158.39	-146.43	-25.26	-33.83
Net Income to Common Margin (%)	- -	- -	- -	- -	-575.12	-158.39	-146.43	-25.26	-33.83
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Total Debt	- -	- -	- -	2	4	4	2	1	1
ST Debt	- -	- -	- -	1	2	2	1	1	1
LT Debt	- -	- -	- -	2	2	2	1	1	- -
Total Debt/EBITDA	- -	- -	- -	-0.03	-0.03	-0.03	-0.02	-0.06	-0.03
Net Debt/EBITDA	0.99	4.7	3.42	2.5	0.96	1.58	1.13	3.15	2.19
Total Debt/EBIT	- -	- -	- -	-0.03	-0.03	-0.03	-0.02	-0.06	-0.03
Net Debt/EBIT	0.99	4.7	3.42	2.5	0.96	1.57	1.12	3.06	2.15
EBITDA to Interest Expense	- -	- -	- -	- -	- -	-61.91	-124.14	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	-62.43	-124.14	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	-62.33	-125.25	- -	- -
Interest Expense	- -	- -	- -	- -	- -	2	1	- -	- -
Common Equity/Total Assets	-129.76	-45.11	-55.84	-76.66	-215.98	-160.01	-308.25	-357.76	-406.27
Long-Term Debt/Equity (%)	- -	- -	- -	0.86	1.9	1.03	0.82	0.51	0.21
Long-Term Debt/Capital (%)	- -	- -	- -	-1.05	-0.72	-0.55	-0.21	-0.11	-0.04
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.79	1.52	0.87	0.64	0.4	0.16
Total Debt/Equity (%)	- -	- -	- -	1.12	3.76	2.02	1.62	1.41	0.89
Total Debt/Capital (%)	- -	- -	- -	-1.36	-1.41	-1.08	-0.41	-0.31	-0.17
Total Debt/Total Assets (%)	- -	- -	- -	1.03	3.01	1.71	1.25	1.11	0.68
Net Debt to Equity	-139.91	-110.14	-105.2	-104.14	-108.31	-100.81	-96.83	-77.87	-73.08
Net Debt/Capital (%)	42.97	68.53	63.54	55.87	28.96	35.02	19.58	14.71	12.15
EBITDA	-17	-19	-43	-83	-120	-115	-94	-25	-31
EBITDA-CapEx	-17	-19	-43	-85	-120	-116	-94	-25	-31
Operating Income (Loss)	-17	-19	-43	-83	-120	-115	-95	-26	-31

Liquidity (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Cash Ratio	5.67	11.42	16.21	15.25	5.87	6.51	3.74	3.91	2.84
Current Ratio	5.8	11.53	16.61	15.6	6.26	7.26	4.61	5.52	4.16
Quick Ratio	5.67	11.42	16.21	15.25	5.87	6.79	4.18	5.02	3.67
CFO/Avg Current Liab	- -	-2.91	-4.84	-6.47	-5.51	-4.33	-2.7	-1.13	-0.72
Common Equity/Total Assets	-129.76	-45.11	-55.84	-76.66	-215.98	-160.01	-308.25	-357.76	-406.27
Long-Term Debt/Equity (%)	- -	- -	- -	0.86	1.9	1.03	0.82	0.51	0.21
Long-Term Debt/Capital (%)	- -	- -	- -	-1.05	-0.72	-0.55	-0.21	-0.11	-0.04
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.79	1.52	0.87	0.64	0.4	0.16
Total Debt/Equity (%)	- -	- -	- -	1.12	3.76	2.02	1.62	1.41	0.89
Total Debt/Capital (%)	- -	- -	- -	-1.36	-1.41	-1.08	-0.41	-0.31	-0.17
Total Debt/Total Assets (%)	- -	- -	- -	1.03	3.01	1.71	1.25	1.11	0.68
CFO/Total Liabilities	-214.73	-159.1	-361.75	-420.87	-348.06	-313.85	-235.52	-101.29	-56.32
CFO/CapEx	- -	- -	-176.19	-37.4	-521.32	-106.06	- -	- -	- -
Altman's Z-Score	-4.08	-0.23	30.21	36.54	40.54	9.95	-1.34	2.4	2.3

Working Capital (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Accounts Receivable Turnover	- -	- -	- -	- -	- -	9.05	6.45	4.85	4.16
Days Sales Outstanding	- -	- -	- -	- -	- -	40.33	56.6	75.28	87.71
Inventory Turnover	- -	- -	- -	- -	- -	0.91	1.24	1.94	2.48
Days Inventory Outstanding	- -	- -	- -	- -	- -	400.14	294.58	188.11	146.94
Accounts Payable Turnover	- -	- -	- -	- -	0.25	0.7	0.63	0.97	2.74
Accounts Payable Turnover Days	- -	- -	- -	- -	1,482.2	521.26	577.84	377.63	133.43
Cash Conversion Cycle	- -	- -	- -	- -	-1,482.2	-80.79	-226.66	-114.25	101.21
Inventory to Cash Days	- -	- -	- -	- -	- -	-359.8	-237.97	-112.84	-59.23
Inventories	- -	- -	- -	- -	- -	6	7	5	7
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	5	6	2	- -
Finished Goods	- -	- -	- -	- -	- -	1	1	3	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	7

Enterprise Value (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Market Capitalization	- -	- -	585	1,099	1,986	700	213	298	347
- Cash & Cash Equivalents	17	90	148	207	115	182	106	79	67
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	2	4	4	2	1	1
Enterprise Value	-17	-90	437	895	1,876	522	109	220	281
Total Capital	-22	-42	-85	-164	-281	-337	-434	-456	-486
Total Debt/Capital (%)	- -	- -	- -	-1.36	-1.41	-1.08	-0.41	-0.31	-0.17
Total Debt / EV	- -	- -	- -	- -	- -	0.01	0.02	0.01	- -
EV/Sales	- -	- -	- -	- -	90.39	14.96	1.67	2.6	3.2
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	585	1,099	1,986	700	213	298	347
Diluted Enterprise Value	-17	-90	437	895	1,876	522	109	220	281
EV per Share	- -	- -	15.2	25.43	46.75	12.09	2.5	5.05	6.33
TTM Sales	- -	- -	- -	- -	21	35	65	85	88
TTM EBITDA	-17	-19	-43	-83	-120	-115	-94	-25	-31
TTM Operating Income	-17	-19	-43	-83	-120	-115	-95	-26	-31
TTM Cash Flow to Firm	-11	-16	-41	-73	-91	-101	-75	-27	-16
TTM Free Cash Flow to Firm	-11	-16	-41	-72	-91	-100	-75	-27	-16

Multiples (USD)

API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024

Price/Free Cash Flow	- -	- -	-14.28	-15.37	-21.81	-6.89	-2.81	-10.93	-22.09
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-17	-90	437	895	1,876	522	109	220	281
Low Price	- -	- -	15.17	18.11	14.16	14.95	2.94	2.7	6.48
EV/Sales	- -	- -	- -	- -	90.39	14.96	1.67	2.6	3.2
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-15.41	-10.88	-12.88	-24.52	-5.24	-11.81	-19.35
Price/Earnings High	- -	- -	-20.61	-14.98	-18.56	-41.55	-9.37	-22.3	-31.23
Price/Earnings Low	- -	- -	-10.09	-7.86	-4.76	-11.68	-1.34	-5.5	-9.68
Price/Book Value	- -	- -	-6.9	-6.63	-6.96	-2.06	-0.49	-0.65	-0.71
Price/Book Value Average	- -	- -	-7.86	-5.32	-5.39	-3.98	-1.15	-0.55	-1.18
Price/Book Value High	- -	- -	-10.51	-7.32	-7.77	-6.74	-2.05	-1.04	-1.9
Price/Book Value Low	- -	- -	-5.15	-3.84	-1.99	-1.9	-0.29	-0.26	-0.59
Price/Tangible Book Value	- -	- -	4.16	5.53	18.77	3.92	2.01	3.03	3.87
Price/Tangible Book Value Average	- -	- -	4.75	4.43	14.52	7.59	4.72	2.57	6.4
Price/Tangible Book Value High	- -	- -	6.35	6.1	20.93	12.87	8.43	4.86	10.33
Price/Tangible Book Value Low	- -	- -	3.11	3.2	5.37	3.62	1.21	1.2	3.2
Price/Sales	- -	- -	- -	- -	95.72	20.06	3.27	3.51	3.96
Price/Sales Average	- -	- -	- -	- -	74.05	38.83	7.68	2.98	6.55
Price/Sales High	- -	- -	- -	- -	106.76	65.81	13.71	5.63	10.57
Price/Sales Low	- -	- -	- -	- -	27.38	18.5	1.97	1.39	3.28
Price/Cash Flow	- -	- -	-14.19	-14.96	-21.77	-6.83	-2.81	-10.93	-22.09
Price/Cash Flow Average	- -	- -	-16.18	-12	-16.84	-13.21	-6.6	-9.29	-36.53
Price/Cash Flow High	- -	- -	-21.63	-16.51	-24.28	-22.39	-11.79	-17.55	-58.96
Price/Cash Flow Low	- -	- -	-10.59	-8.67	-6.23	-6.29	-1.69	-4.33	-18.28
Price/Free Cash Flow Average	- -	- -	-16.27	-12.33	-16.87	-13.34	-6.6	-9.29	-36.53
Price/Free Cash Flow High	- -	- -	-21.76	-16.96	-24.33	-22.6	-11.79	-17.55	-58.96
Price/Free Cash Flow Low	- -	- -	-10.65	-8.91	-6.24	-6.35	-1.69	-4.33	-18.28
EV/Sales Average	- -	- -	- -	- -	68.72	33.73	6.08	2.07	5.79
EV/Sales High	- -	- -	- -	- -	101.43	60.71	12.12	4.72	9.81
EV/Sales Low	- -	- -	- -	- -	22.04	13.4	0.38	0.48	2.52
EV/EBITDA Average	0.99	4.7	-12.01	-8.17	-11.93	-10.27	-4.23	-7.05	-16.55
EV/EBITDA High	0.99	4.7	-17.22	-12.18	-17.61	-18.48	-8.42	-16.07	-28.05
EV/EBITDA Low	0.99	4.7	-6.68	-5.22	-3.83	-4.08	-0.26	-1.63	-7.2
EV/EBIT Average	0.99	4.7	-12.01	-8.15	-11.89	-10.2	-4.19	-6.85	-16.27
EV/EBIT High	0.99	4.7	-17.21	-12.15	-17.55	-18.35	-8.34	-15.61	-27.57
EV/EBIT Low	0.99	4.7	-6.68	-5.21	-3.81	-4.05	-0.26	-1.58	-7.08
Last Price	- -	- -	20.34	31.25	49.51	16.21	4.88	6.82	7.83
High Price	- -	- -	31	34.49	55.22	53.18	20.48	10.95	20.9
Enterprise Value Average	-17	-90	519	677	1,426	1,177	397	176	508
Enterprise Value High	-17	-90	744	1,009	2,105	2,118	791	401	860
Enterprise Value Low	-17	-90	289	432	457	468	24	41	221

Shares Outstanding	33	34	34	40	41	44	44	44	45
Diluted Weighted Avg Shares	33	33	29	35	40	43	44	44	44
Basic Weighted Avg Shares	33	33	29	35	40	43	44	44	44
Revenue per Share	- -	- -	- -	- -	0.52	0.81	1.49	1.94	1.98
EBITDA per Share	-0.51	-0.58	-1.5	-2.35	-2.98	-2.66	-2.15	-0.57	-0.69
Operating Income per Share	-0.51	-0.58	-1.5	-2.36	-2.99	-2.67	-2.17	-0.59	-0.7
Basic EPS, GAAP	-0.51	-0.58	-1.5	-2.3	-2.97	-1.28	-2.19	-0.49	-0.67
Basic EPS from Cont Ops	-0.51	-0.58	-1.5	-2.3	-2.97	-1.28	-2.19	-0.49	-0.67
Diluted EPS, GAAP	-0.51	-0.58	-1.5	-2.3	-2.97	-1.28	-2.19	-0.49	-0.67
Diluted EPS from Cont Ops	-0.51	-0.58	-1.5	-2.3	-2.97	-1.28	-2.19	-0.49	-0.67
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.34	-0.48	-1.43	-2.09	-2.27	-2.37	-1.74	-0.62	-0.35
Free Cash Flow per Basic Share	-0.34	-0.48	-1.44	-2.14	-2.28	-2.4	-1.74	-0.62	-0.35
Cash & Equivalents per Share	0.51	2.72	5.14	5.89	2.86	4.2	2.42	1.8	1.52
Book Value per Share	-0.67	-1.25	-2.95	-4.71	-7.11	-7.88	-9.98	-10.48	-10.99
Tangible Book Value per Share	0.36	2.47	4.88	5.65	2.64	4.13	2.43	2.25	2.02

Y-mAbs Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)